Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,320,778
-
Share change
-
+270,964
-
Total reported value
-
$7,145,290
-
Price per share
-
$5.41
-
Number of holders
-
31
-
Value change
-
+$1,393,786
-
Number of buys
-
19
-
Number of sells
-
15
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q4 2024
As of 31 Dec 2024,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,320,778 shares.
The largest 10 holders included
BALDWIN WEALTH PARTNERS LLC/MA, VANGUARD GROUP INC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., FORBES J M & CO LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GSA CAPITAL PARTNERS LLP, Qube Research & Technologies Ltd, and MILLENNIUM MANAGEMENT LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.